David J. Mack
Director · BioXcel Therapeutics, Inc.
Individual
- 2024
- Nov 3, 2025
- 6
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David J. Mack files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vimal Mehta - $21K in BTAI purchases and sales in the last 12 months
- Richard I. Steinhart - $7K in BTAI purchases and sales in the last 12 months
- Frank Yocca - $7K in BTAI purchases and sales in the last 12 months
- Javier Rodriguez - $7K in BTAI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David J. Mack?
David J. Mack is a corporate insider, tracked as Director of BioXcel Therapeutics, Inc. (BTAI). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David J. Mack last file a Form 4?
The most recent primary Form 4 on record is dated 3 November 2025, one of 6 filings going back to 2024.
